VOYA Investment Management
CDTX

VOYA Investment Management’s Cidara Therapeutics CDTX Stock Holding History

VOYA Investment Management’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,453
Closed -$763K – 2368
2025
Q4 		$763K Buy
3,453
+598
+21% +$96.7K ﹤0.01% 1575
2025
Q3 		$273K Sell
2,855
-1,776
-38% -$113K ﹤0.01% 2033
2025
Q2 		$226K Buy
+4,631
New +$111K ﹤0.01% 2277
2021
Q2 		– Sell
-911
Closed -$48K – 2825
2021
Q1 		$48K Hold
911
– – ﹤0.01% 2747
2020
Q4 		$36K Buy
911
+367
+67% +$18.3K ﹤0.01% 2676
2020
Q3 		$31K Buy
+544
New +$38.4K ﹤0.01% 2477

VOYA Investment Management's CDTX Position: Q1 2026 in Review

VOYA Investment Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 3,453 shares — an estimated $763K sold.

VOYA Investment Management first reported a position in CDTX in Q3 2020 and held it in 6 quarters. The position peaked at $763K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • VOYA Investment Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • VOYA Investment Management sold 3,453 Cidara Therapeutics shares in Q1 2026, an estimated $763K.
  • VOYA Investment Management first reported a position in Cidara Therapeutics in Q3 2020 and held it in 6 quarters.
  • VOYA Investment Management's Cidara Therapeutics position peaked at $763K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.